What You Should Know
- The Deal: Healthcare tech companies DoseSpot and Arrive Health have officially merged to form Interra Health.
- The Backers: The deal is backed by Bain Capital Tech Opportunities as the majority owner, with PSG (DoseSpot’s former majority owner), Providence, and UPMC Enterprises holding minority stakes.
- The Scale: The combined entity is already profitable, growing at approximately 40% annually, and is projected to exceed $100 million in revenue in 2026. Together, they serve roughly 800,000 prescribers (marrying Arrive’s ~700,000 provider network with DoseSpot’s 100,000 prescribers).
- The Mission: Interra Health aims to solve the “black box” of prescription pricing by embedding real-time affordability, coverage, and pharmacy alternative data directly into the provider’s electronic prescribing workflow.
- The Leadership: Former DoseSpot CEO Josh Weiner will lead the new company as CEO, while former Arrive Health CEO Kyle Kiser transitions to a board member and senior advisor role.
“Medication affordability is too often a complex journey for patients and providers,” said Kyle Kiser, Senior Advisor and Board Member at Interra Health. “Interra Health provides the technology infrastructure that brings affordability insights forward, giving patients clear information and meaningful choice at the right moment.”
